NEU 0.45% $20.00 neuren pharmaceuticals limited

Ann: Neuren presents at Rettsyndrome.org 2016 Research Symposium-NEU.AX, page-4

  1. 65 Posts.
    lightbulb Created with Sketch. 4
    I wonder what the outcome would have been had the efficacy assessment been based on mba alone. Would that constitute proof and we would be progressing rapidly to commercialisation?

    If they have got fda signed off on mba as the efficacy criteria, as could be assumed from their comments, surely NEU just has to repeat the same outcome and we are in business. I am pretty optimistic.
    Last edited by McKracken: 28/06/16
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.00
Change
0.090(0.45%)
Mkt cap ! $2.556B
Open High Low Value Volume
$19.88 $20.07 $19.73 $11.80M 591.1K

Buyers (Bids)

No. Vol. Price($)
2 5901 $19.97
 

Sellers (Offers)

Price($) Vol. No.
$20.00 3262 5
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.